Last reviewed · How we verify
NCT06615271: UPS
Pressure Injuries in the Operating Room and Their Perioperative Incidence in Patients Undergoing Neurosurgery.
trial testing Neurosurgery in PRESSURE INJURIES in 170 participants. Currently enrolling.
1 December 2024
Quick facts
| Lead sponsor | Instituto de Investigación Marqués de Valdecilla |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 170 |
| Start date | 1 December 2023 |
| Primary completion | 1 December 2024 |
| Estimated completion | 1 January 2025 |
| Sites | 2 locations across Spain |
Drugs / interventions tested
- Neurosurgery
Conditions studied
- PRESSURE INJURIES — all drugs for PRESSURE INJURIES →
Sponsor
Instituto de Investigación Marqués de Valdecilla — full company profile →
Who can join
Adults 18 to 100, any sex, with PRESSURE INJURIES. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research project is a descriptive, longitudinal prospective observational study in the HUMV neurosurgery operating rooms. The patients included will be adults 18 years old or older, who will be scheduled for surgery by the Neurosurgery service. Those who meet the selection criteria determined for this study will be chosen consecutively and will be followed from the immediate preoperative moment until 72 hours after the end of the surgery. Data collection shall be carried out by direct observation and immersion in clinical records of patients who have signed the informed consent. The study will be carried out in 4 phases: immediate preoperative, intraoperative, immediate postoperative and late postoperative, recording the data using various measuring instruments, and a record sheet. Finally, the cumulative incidence of LPPs developed in the perioperative environment will be calculated and a statistical analysis will be performed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06615271
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Neurosurgery
Trials testing the same drug.
- NCT05264012 — Incidence, Risk Factors and Impact of Significant Pain in Patients Undergoing Neurosurgery · completed
- NCT04074642 — OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroade · NA · completed
Other Instituto de Investigación Marqués de Valdecilla trials
Trials by the same sponsor.
- NCT07113184 — Randomized a Clinical Trial With Medical Device in Acute Ischemic Stroke · NA · not yet recruiting
- NCT06908785 — Utility of ROTEM® for Risk Stratification of Post-Invasive Procedure Hemorrhage in Patients With Cirrhosis (CIR-ROTEM) · recruiting
- NCT05622526 — Evaluate the Efficacy, Safety and Tolerability of Fecal Microbiota Transfer for the Treatment of Patients With Nonalcoho · Phase 2 · unknown
- NCT06753578 — Effectiveness of an ACT-Based Cognitive Intervention on Quality of Life and Cognitive Function in Elderly Residents With · NA · recruiting
- NCT05923047 — Mepolizumab and In-office Nasal Polypectomy in Patients With Chronic Rhinosinusitis (CRS). A Three Arm Study. · Phase 4 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06615271 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto de Investigación Marqués de Valdecilla
- Last refreshed: 26 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06615271.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing